Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung disease

被引：0
|
作者：
Moon Ki Choi
Jung Yong Hong
Wonjin Chang
Moonjin Kim
Sungmin Kim
Hyun Ae Jung
Su Jin Lee
Silvia Park
Man Pyo Chung
Jong-Mu Sun
Keunchil Park
Myung-Ju Ahn
Jin Seok Ahn
机构：
[1] Sungkyunkwan University School of Medicine,Division of Hematology
[2] Sungkyunkwan University School of Medicine,Oncology, Department of Medicine, Samsung Medical Center
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 73卷
关键词：
Non-small-cell lung cancer; Interstitial lung disease; Chemotherapy; Platinum doublet;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：1217 / 1225
页数：8
相关论文
共 50 条
  • [31] Efficacy and Safety of Nivolumab in Non-Small Cell Lung Cancer with Preexisting Interstitial Lung Disease
    Kanai, O.
    Kim, Y.
    Demura, Y.
    Kanai, M.
    Fujita, K.
    Yoshida, H.
    Akai, M.
    Mio, T.
    Hirai, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2420 - S2420
  • [32] THE RISK OF TREATMENT WITH PEMETREXED PLUS PLATINUM FOLLOWED BY MAINTENANCE WITH PEMETREXED FOR PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER CONCURRENT WITH INTERSTITIAL LUNG DISEASE
    Fujita, Tetsuo
    Kuroki, Tsuguko
    Shiraishi, Yuka
    Amano, Hiroyuki
    Nakamura, Makoto
    Hirano, Satoshi
    Tabeta, Hiroshi
    Nakamura, Sukeyuki
    CHEST, 2019, 156 (04) : 1716A - 1716A
  • [33] Cisplatin and gemcitabine in non-small-cell lung cancer
    Cartei, G
    Sacco, C
    Sibau, A
    Pella, N
    Iop, A
    Tabaro, G
    ANNALS OF ONCOLOGY, 1999, 10 : 57 - 62
  • [34] Gemcitabine for the treatment of non-small-cell lung cancer
    Johnson, DH
    ONCOLOGY-NEW YORK, 2001, 15 (03): : 33 - 39
  • [35] The use of gemcitabine in non-small-cell lung cancer
    Gatzemeier, U
    Peters, HD
    UPDATES IN ADVANCES IN LUNG CANCER, 1997, 29 : 91 - 105
  • [36] Gefitinib exposure and occurrence of interstitial lung disease in Japanese patients with non-small-cell lung cancer
    Kawata, Toshio
    Higashimori, Mitsuo
    Itoh, Yohji
    Tomkinson, Helen
    Johnson, Martin G.
    Tang, Weifeng
    Nyberg, Fredrik
    Jiang, Haiyi
    Tanigawara, Yusuke
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 849 - 858
  • [37] Gemcitabine in the treatment of non-small-cell lung cancer
    Burkes, RL
    Shepherd, FA
    ANNALS OF ONCOLOGY, 1995, 6 : 57 - 60
  • [38] Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management - Introduction
    Camus, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (Suppl 2) : S1 - S2
  • [39] Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non-Small-Cell Lung Cancer
    Chang, Shih-Chieh
    Chang, Cheng-Yu
    Chang, Shu-Ju
    Yuan, Mei-Kang
    Lai, Yi-Chun
    Liu, Yu-Chang
    Chen, Cheng-Yu
    Kuo, Li-Chiao
    Yu, Chong-Jen
    CLINICAL LUNG CANCER, 2013, 14 (01) : 55 - 61
  • [40] Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease with Small Cell Lung Cancer
    Uchiyama, A.
    Nagai, Y.
    Takigami, A.
    Sata, M.
    Hagiwara, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S793 - S794
12345